Beth Cameron Joins NTI to Lead Global Biological Policy and Programs
founding, NTI has been committed to addressing biological threats,” said Nunn.
“We are very pleased that Beth will be joining NTI to oversee this important
work. She has outstanding credentials
and has the experience, leadership and drive to expand and advance NTI’s work
in this arena.”
duties, Dr. Cameron will oversee the development of a Global Health Security
Index, as well as work related to national security risks associated with
emerging biotechnologies. The Index was announced by NTI earlier this month
in partnership with the Open Philanthropy Project, the Robertson Foundation and
the Johns Hopkins Center for Health Security.
Dr. Cameron most
recently served as the Senior Director for Global Health Security and Biodefense
on the White House National Security Council staff, where she was instrumental
in developing, launching, and implementing the Global Health Security Agenda. In this role, she reported to the National
Security Advisor and the Assistant to the President for Homeland Security and
Counterterrorism in addressing homeland and national security issues surrounding
biosecurity and biosafety, biodefense, emerging infectious disease threats, biological
select agents and toxins, dual‐use research, and
Dr. Cameron served at the U.S. Department of Defense as office director for
Cooperative Threat Reduction (CTR) and senior advisor for the Assistant
Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. In
this role, she oversaw implementation of the geographic expansion of the Nunn‐Lugar
Cameron oversaw expansion of the U.S. Department of State’s Global Threat
Reduction programs and supported the expansion and extension of the Global
Partnership Against the Spread of Weapons and Materials of Mass Destruction, a
multilateral framework to improve global chemical, biological, radiological and
About the Nuclear Threat Initiative
Nuclear Threat Initiative works to protect our lives, environment, and quality
of life now and for future generations. We work to prevent catastrophic attacks
with weapons of mass destruction and disruption (WMDD)—nuclear, biological,
radiological, chemical, and cyber. Founded in 2001 by former U.S. Senator Sam
Nunn and philanthropist Ted Turner, NTI is guided by a prestigious,
international board of directors. Sam Nunn serves as chief executive officer;
Des Browne is vice chairman; and Joan Rohlfing serves as president.
Former Energy Secretary Ernest J. Moniz will become CEO and join Nunn and
Turner as co-chairmen on June 1. More
about NTI’s biosecurity program can be found here. Find out more about the development of the
new index here.
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI-WEF Technical Consortium for DNA Synthesis Screening Comments on Revised U.S. Government Guidance
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
NTI | bio Experts in Singapore for International Conference to Strengthen Global Health Security
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
Winners of 2022 Next Generation for Biosecurity Competition Announced
Nicholas Cropper, Shrestha Rath, and Ryan Teo are the winners of the Sixth Annual Next Generation for Biosecurity Competition.